Validation of AFP Model as a Predictor of Response, Recurrence and Survival in HCC Patients Underwent Locoregional Treatment
Mohamed Atef Abu Hashima;
Abstract
CC represents approximately 90% of all primary liver cancer cases, shows a clear gender disparity towards males and is a major cancer in less developed regions, with a correlation to HBs Ag prevalence.
Chronic HBV and HCV infections represent the leading cause for HCC (60–70%), with a total incidence of 16/100 000 globally. In most of Africa and Asia, HBV is the single leading risk factor for HCC, whereas in Japan, northern Europe, Egypt and the USA HCV is the major risk factor.
Recently AFP model proposed as prognostic tool which was designed in a French training cohort of HCC candidates it has been shown to be more accurate than Milan criteria for selecting HCC candidates in this French population.
Chronic HBV and HCV infections represent the leading cause for HCC (60–70%), with a total incidence of 16/100 000 globally. In most of Africa and Asia, HBV is the single leading risk factor for HCC, whereas in Japan, northern Europe, Egypt and the USA HCV is the major risk factor.
Recently AFP model proposed as prognostic tool which was designed in a French training cohort of HCC candidates it has been shown to be more accurate than Milan criteria for selecting HCC candidates in this French population.
Other data
| Title | Validation of AFP Model as a Predictor of Response, Recurrence and Survival in HCC Patients Underwent Locoregional Treatment | Other Titles | التحقق من نموذج بروتين الفا فيتو كمؤشر للاستجابه، وعودة ظهور سرطان الكبد والبقاء على قيد الحياة في مرضى سرطان الكبد الاولي بعد الخضوع للعلاج الموضعي بالحقن الكيماوي اوالتردد الحراري | Authors | Mohamed Atef Abu Hashima | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.